AS
Aslan Pharma
ASLN·NASDAQSingapore SGFounded 201060 employees
Micro CapbiotechPublicOncologyImmunology
Platform: IL-13Rα2
Market Cap
$0.2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ASLN)
Loading ASLN stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Polasotorasib | ASL-7069 | NDA/BLA | 1 | FXIa | SCLCCeliac | ||
| ASL-9777 | ASL-9777 | Phase 2 | 1 | AHR | UC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)